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Cistanche phelypaea L. is a chlorophyll-free obligate parasitic plant distributed in some 
arid and semi-arid regions. It is also an edible plant like other species of Cistanche 
genus composed by a variety of phenylethanoid glycosides (PhGs), iridoids, and lignans. 
These bioactive ingredients are used for treatment of a wide range of human disease 
[1-3], therefore in this study, ethyl acetate, acetone, ethanol and water extracts from 
flowers, stems and roots of C. phelypaea were appraise for in vitro antioxidant activity. 
Therefore, since the water extracts had the highest antioxidant capacity, they were 
further evaluated for enzymatic inhibition related with the onset of 
acetylcholinesterase and butyrylcholinesterase, type 2 diabetes mellitus and skin 
hyperpigmentation (tyrosinase). 
The structural characterization of water extracts was performed by NMR (1D and 2D) 
analyses. The secondary metabolites present in C. phelypaea water extracts showed 
differences in each sections studied of this plant: in stems, PhGs and iridoids were 
detected, especially acteoside; in roots were detected essentially PhGs, mainly 
echinacoside and tubuloside A.  
Finally, docking studies were performed on the identified compounds, and indicated 
this compound as a possible competitive inhibitor of glucosidase and tyrosinase.  
Our results suggest that C. phelypaea is a promising source of biologically active 
compounds with health promoting properties for pharmaceutical applications. 
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